Literature DB >> 24301753

Expression profile analysis reveals putative prostate cancer-related microRNAs.

H Song1, Y Liu, J Pan, S T Zhao.   

Abstract

Annotation of prostate cancer (PC) genomes provides a foundation for discoveries that can improve the understanding and treatment of the disease. Therefore, in the present study, we used the Student t-test to identify differentially expressed PC-related mRNAs and microRNAs (miRNAs). Then, we performed interrelated mapping of miRNA target genes between abnormally expressed mRNAs and miRNAs, and explored mRNA-target miRNA interrelated pairs to explain the biological functions of miRNA during the progression of PC, thus revealing the occurrence of miRNA-mediated PC. After Gene Set Functional Similarity analysis, we obtained 20 abnormal PC-related candidate miRNAs, including hsa-miR-26a, hsa-miR-152, hsa-miR-19a, hsa-miR-30c, hsa-miR-19b, and hsa-miR-146b-5p, among others. These results suggest that it may be possible to predict the clinical behavior of prostate cancer based on gene expression analysis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24301753     DOI: 10.4238/2013.October.24.4

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  13 in total

1.  Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.

Authors:  Qing Cao; Kunlin Lu; Suiping Dai; Yan Hu; Weifang Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

2.  Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.

Authors:  Darina Kachakova; Atanaska Mitkova; Elenko Popov; Ivan Popov; Alexandrina Vlahova; Tihomir Dikov; Svetlana Christova; Vanio Mitev; Chavdar Slavov; Radka Kaneva
Journal:  DNA Cell Biol       Date:  2014-12-18       Impact factor: 3.311

3.  Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1.

Authors:  Jing Zou; Ling Liu; Qi Wang; Fuqiang Yin; Zhijun Yang; Wei Zhang; Li Li
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

4.  DGCR8 is essential for tumor progression following PTEN loss in the prostate.

Authors:  Cassandra D Belair; Alireza Paikari; Felix Moltzahn; Archana Shenoy; Christina Yau; Marc Dall'Era; Jeff Simko; Christopher Benz; Robert Blelloch
Journal:  EMBO Rep       Date:  2015-07-23       Impact factor: 8.807

5.  Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.

Authors:  Kai Guo; Shaobo Zheng; Yawen Xu; Abai Xu; Binshen Chen; Yong Wen
Journal:  Tumour Biol       Date:  2016-07-23

6.  MiR-26a inhibits prostate cancer progression by repression of Wnt5a.

Authors:  Shijia Zhao; Xiangdong Ye; Lei Xiao; Xuexiong Lian; Yupeng Feng; Feng Li; Li Li
Journal:  Tumour Biol       Date:  2014-06-28

7.  Regulation of human growth hormone receptor expression by microRNAs.

Authors:  Samar Elzein; Cynthia Gates Goodyer
Journal:  Mol Endocrinol       Date:  2014-07-29

8.  Association of miRNA 30c, miRNA 181a and miRNA 570 SNPs with Bladder Cancer Risk in North Indian Population: A Pilot Study.

Authors:  Archana Verma; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2020-04-04

9.  Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.

Authors:  Zhang Xiaoli; Wei Yawei; Liu Lianna; Li Haifeng; Zhang Hui
Journal:  Med Sci Monit       Date:  2015-12-02

10.  Studying the system-level involvement of microRNAs in Parkinson's disease.

Authors:  Paulami Chatterjee; Malay Bhattacharyya; Sanghamitra Bandyopadhyay; Debjani Roy
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.